Influence of physical and radiobiological models on evaluation of radiotherapy treatment fractionation schedules for GBM brain tumours

References

• Joiner MC, van der Kogel AJ. Basic clinical radiobiology. CRC Press; 2018.
   Google Scholar
• Maringe C, Spicer J, Morris M, et al. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol. 2020;21(8):1023–1034. doi:10.1016/S1470-2045(20)30388-0
   PubMed Web of Science ®Google Scholar
• Hashemi FA, Barzegartahamtan M, Mohammadpour RA, et al. Comparison of conventional and hypofractionated radiotherapy in breast cancer patients in terms of 5-year survival, locoregional recurrence, late skin complications and cosmetic results. APJCP. 2016;17(11):4819.
   Google Scholar
• Ågren A, Brahme A, Turesson I. Optimization of uncomplicated control for head and neck tumors. Int J Radiat Oncol Biol Phys. 1990;19(4):1077–1085. doi:10.1016/0360-3016(90)90037-K
   PubMed Web of Science ®Google Scholar
• Chaikh A, Docquière N, Bondiau P-Y, et al. Impact of dose calculation models on radiotherapy outcomes and quality adjusted life years for lung cancer treatment: do we need to measure radiotherapy outcomes to tune the radiobiological parameters of a normal tissue complication probability model? Transl Lung Cancer Res. 2016;5(6):673. doi:10.21037/tlcr.2016.11.04
   PubMed Web of Science ®Google Scholar
• Chargari C, Magne N, Guy J-B, et al. Optimize and refine therapeutic index in radiation therapy: overview of a century. Cancer Treat Rev. 2016;45:58–67. doi:10.1016/j.ctrv.2016.03.001
   PubMed Web of Science ®Google Scholar
• Brand D, Kirby AM, Yarnold JR, et al. How low can you go? The radiobiology of hypofractionation. Clin Oncol. 2022;34(5):280–287. doi:10.1016/j.clon.2022.02.009
   Web of Science ®Google Scholar
• Holland EC. Glioblastoma multiforme: the terminator. Proc Natl Acad Sci USA. 2000;97(12):6242–6244. doi:10.1073/pnas.97.12.6242
   PubMed Web of Science ®Google Scholar
• Iocolano M, Wild AT, Hannum M, et al. Hypofractionated vs. conventional radiation therapy for stage III non-small cell lung cancer treated without chemotherapy. Acta Oncol. 2020;59(2):164–170. doi:10.1080/0284186X.2019.1675907
   PubMed Web of Science ®Google Scholar
• Wang S-L, Fang H, Song Y-W, et al. Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial. Lancet Oncol. 2019;20(3):352–360. doi:10.1016/S1470-2045(18)30813-1
   PubMed Web of Science ®Google Scholar
• Liu L, Yang Y, Gao Q, et al. Comparing hypofractionated to conventional fractionated radiotherapy in postmastectomy breast cancer: a meta-analysis and systematic review. Radiat Oncol. 2020;15(1):17. doi:10.1186/s13014-019-1449-z
   PubMed Web of Science ®Google Scholar
• Powell AC, Rogstad TL, Jacob NM, et al. The association between use of hypofractionation and treatment completion among recipients of radiation therapy post-mastectomy. Pract Radiat Oncol. 2020;10(4):e244–e249. doi:10.1016/j.prro.2019.10.009
   PubMed Web of Science ®Google Scholar
• Reddy K, Damek D, Gaspar LE, et al. Phase II trial of hypofractionated IMRT with temozolomide for patients with newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 2012;84(3):655–660. doi:10.1016/j.ijrobp.2012.01.035
   PubMed Web of Science ®Google Scholar
• Alfonso L, Herrero JMA, Nunez L. A dose-volume histogram based decision-support system for dosimetric comparison of radiotherapy treatment plans. Radiat Oncol. 2015;10(1):1–9. doi:10.1186/s13014-015-0569-3
   PubMedGoogle Scholar
• Feuvret L, Noël G, Mazeron J-J, et al. Conformity index: a review. Int J Radiat Oncol Biol Phys. 2006;64(2):333–342. doi:10.1016/j.ijrobp.2005.09.028
   PubMed Web of Science ®Google Scholar
• Oermann E, Collins BT, Erickson KT, et al. Cyberknife® enhanced conventionally fractionated chemoradiation for high grade glioma in close proximity to critical structures. J Hematol Oncol. 2010;3(1):1–9. doi:10.1186/1756-8722-3-22
   PubMedGoogle Scholar
• Deasy JO, Blanco AI, Clark VH. CERR: a computational environment for radiotherapy research. Med Phys. 2003;30(5):979–985. doi:10.1118/1.1568978
   PubMed Web of Science ®Google Scholar
• Emami B. Tolerance of normal tissue to therapeutic radiation. Rep Radiother Oncol. 2013;1(1):123–127. https://applications.emro.who.int/imemrf/Rep_Radiother_Oncol/Rep_Radiother_Oncol_2013_1_1_35_48.pdf
   Google Scholar
• Yoon M, Park SY, Shin D, et al. A new homogeneity index based on statistical analysis of the dose–volume histogram. J Appl Clin Med Phys. 2007;8(2):9–17. doi:10.1120/jacmp.v8i2.2390
   PubMed Web of Science ®Google Scholar
• Dhabaan A, Elder E, Schreibmann E, et al. Dosimetric performance of the new high-definition multileaf collimator for intracranial stereotactic radiosurgery. J Appl Clin Med Phys. 2010;11(3):197–211. doi:10.1120/jacmp.v11i3.3040
   Web of Science ®Google Scholar
• Knöös T, Kristensen I, Nilsson P. Volumetric and dosimetric evaluation of radiation treatment plans: radiation conformity index. Int J Radiat Oncol Biol Phys. 1998;42(5):1169–1176. doi:10.1016/S0360-3016(98)00239-9
   PubMed Web of Science ®Google Scholar
• Menhel J, Levin D, Alezra D, et al. Assessing the quality of conformal treatment planning: a new tool for quantitative comparison. Phys Med Biol. 2006;51(20):5363. doi:10.1088/0031-9155/51/20/019
   PubMed Web of Science ®Google Scholar
• Pyakuryal A, Myint WK, Gopalakrishnan M, et al. A computational tool for the efficient analysis of dose-volume histograms for radiation therapy treatment plans. J Appl Clin Med Phys. 2010;11(1):137–157. doi:10.1120/jacmp.v11i1.3013
   Web of Science ®Google Scholar
• Niemierko A. Reporting and analyzing dose distributions: a concept of equivalent uniform dose. Med Phys. 1997;24(1):103–110. doi:10.1118/1.598063
   PubMed Web of Science ®Google Scholar
• Okunieff P, Morgan D, Niemierko A, et al. Radiation dose-response of human tumors. Int J Radiat Oncol Biol Phys. 1995;32(4):1227–1237. doi:10.1016/0360-3016(94)00475-Z
   PubMed Web of Science ®Google Scholar
• Gay HA, Niemierko A. A free program for calculating EUD-based NTCP and TCP in external beam radiotherapy. Phys Med. 2007;23(3-4):115–125. doi:10.1016/j.ejmp.2007.07.001
   PubMed Web of Science ®Google Scholar
• Kallman P, Lind B, Brahme A. An algorithm for maximizing the probability of complication-free tumour control in radiation therapy. Phys Med Biol. 1992;37(4):871–890. doi:10.1088/0031-9155/37/4/004
   PubMed Web of Science ®Google Scholar
• Mallick S, Rath GK, Benson R. Practical radiation oncology. Springer; 2019.
   Google Scholar
• Zeman EM, Schreiber EC, Tepper JE. Basics of radiation therapy. In: Abeloff's clinical oncology. Elsevier; 2020. p. 431–460.e3. https://www.sciencedirect.com/science/article/abs/pii/B978032347674400027X
   Google Scholar
• Burman C, Kutcher GJ, Emami B, et al. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys. 1991;21(1):123–135. doi:10.1016/0360-3016(91)90172-Z
   PubMed Web of Science ®Google Scholar
• Banisharif S, Shahbazi-Gahrouei D, Akhavan A, et al. Determining the optimum tumor control probability model in radiotherapy of glioblastoma multiforme using magnetic resonance imaging data pre-and post-radiation therapy. J Res Med Sci. 2022;27:10. doi:10.4103/jrms.JRMS_1138_20
   PubMed Web of Science ®Google Scholar
• Amin A, El Sayed S, Ezzat A. Dosimetric evaluation of advanced radiotherapy techniques in treating patients with prostatic cancer. Res Oncol. 2017;13(2):40–45. doi:10.21608/resoncol.2017.1654.1036
   Google Scholar
• Cao T, Dai Z, Ding Z, et al. Analysis of different evaluation indexes for prostate stereotactic body radiation therapy plans: conformity index, homogeneity index and gradient index. Precis Radiat Oncol. 2019;3(3):72–79. doi:10.1002/pro6.1072
   Google Scholar
• Inal A, Duman E, Ozkan EE. Evaluating different radiotherapy treatment plans, in terms of critical organ scoring index, conformity index, tumor control probability, and normal tissue complication probability calculations in early glottic larynx carcinoma. J Cancer Res Ther. 2020;16(3):485–493. doi:10.4103/jcrt.JCRT_888_18
   PubMed Web of Science ®Google Scholar
• MacDonald SM, Ahmad S, Kachris S, et al. Intensity modulated radiation therapy versus three-dimensional conformal radiation therapy for the treatment of high grade glioma: a dosimetric comparison. J Appl Clin Med Phys. 2007;8(2):47–60. doi:10.1120/jacmp.v8i2.2423
   PubMed Web of Science ®Google Scholar
• Patel GR, Mandal A, Mishra R, et al. Role of overall treatment time when estimating TCP & NTCP of head & neck radiotherapy treatment plans in altered fractionation. Iran J Med Phys. 2022.
   Google Scholar
• Spohn SK, Sachpazidis I, Wiehle R, et al. Influence of urethra sparing on tumor control probability and normal tissue complication probability in focal dose escalated hypofractionated radiotherapy: a planning study based on histopathology reference. Front Oncol. 2021;11:652678. doi:10.3389/fonc.2021.652678
   PubMed Web of Science ®Google Scholar